Geron Corporation (NASDAQ:GERN) finished Thursday with a subtraction of -$0.01 to close at $3.01, a downside of -0.33 percent. An average of 5,171,100 shares of common stock have been traded in the last five days. There was a fall of -$0.15 in the past week, and it reached a new high 11 times over the past 12 months. The last 20 days have seen an average of 3,267,390 shares traded, while the 50-day average volume stands at 5,402,964.
GERN stock has decreased by -5.05% in the last month. The company shares reached their 1-month lowest point of $2.88 on 08/08/23. With the stock rallying to its 52-week high on 01/04/23, shares of the company touched a low of $1.95 and a high of $3.84 in 52 weeks. It has reached a new high 2 times so far this year and achieved 24.38% or $0.59 in price. In spite of this, the price is down -21.61% from the 52-week high.
Insider Transactions
GERN stock investors should be aware that Geron Corporation (GERN) stock had its last reported insider trading activity 92 days ago on May 11. In this transaction, the insider spent $105,000. Director, Molineaux Susan, disposed of 35,000 shares at a price of $2.48 on May 01. The insider now owns more than $86,800 worth of shares. Prior to that, Chairman, President and CEO SCARLETT JOHN A went on to Sale 446,668 shares at $3.00 each on Feb 10. An amount of $1,340,004 was transacted.
Valuation Metrics
Geron Corporation (GERN) stock’s beta is 0.80. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3269.70, the price-to-book (PB) ratio at 5.28.
Financial Health
The quick ratio of Geron Corporation for the three months ended June 29 was 5.20, and the current ratio was 5.20, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.14 and a total debt to equity ratio of 0.17 for the quarter ending June 29. Geron Corporation’s EBITDA margin for the year ending June 29 is -23101.01%. Its gross profit as reported stood at $139.15 million compared to revenue of $0.6 million.
Earnings Surprise
For the three-month period that ended June 29, Geron Corporation had $314.48 million in cash and short-term investments compared to $40.8 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$49.23 million in the quarter, while revenues of -$38.12 million were grew 42.88%. The analyst consensus anticipated Geron Corporation’s latest quarter earnings to come in at -$0.08 per share, but it turned out to be -$0.09, a -12.50% surprise. For the quarter, EBITDA amounted to -$54.67 million. Shareholders own equity worth $523.37 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Geron Corporation (GERN) price momentum. RSI 9-day as of the close on 10 August was 42.89%, suggesting the stock is Neutral, with historical volatility in this time frame at 38.30%.
As of today, GERN’s price is $2.97 -4.75% or -$0.15 from its 5-day moving average. GERN is currently trading -6.23% lower than its 20-day SMA and +18.97% higher than its 100-day SMA. However, the stock’s current price level is -9.34% below the SMA50 and +29.74% above the SMA200.
The stochastic %K and %D were 31.97% and 23.38%, respectively, and the average true range (ATR) was 0.13. With the 14-day stochastic at 36.00% and the average true range at 0.13, the RSI (14) stands at 44.34%. The stock has reached -0.08 on the 9-day MACD Oscillator while the 14-day reading was at -0.07.
Analyst Ratings
Goldman launched coverage on Geron Corporation (NASDAQ: GERN) in its analyst report released on March 28, 2023. The firm assigned the stock a Neutral rating. The consensus rating for Geron Corporation (GERN) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell GERN, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 4 others rate it as a “buy”.
What is GERN’s price target for the next 12 months?
Analysts predict a range of price targets between $4.00 and $6.00, with a median target of $5.00. Taking a look at these predictions, the average price target given by analysts for Geron Corporation (GERN) stock is $4.83.
